GET THE APP

Exploring the Intersection of Dental Care and Oncology: Addressing Oral Health in Cancer Therapy
..

Journal of Integrative Oncology

ISSN: 2329-6771

Open Access

Commentary - (2024) Volume 13, Issue 4

Exploring the Intersection of Dental Care and Oncology: Addressing Oral Health in Cancer Therapy

Ankur Breyn*
*Correspondence: Ankur Breyn, Department of Oncology, University of Manchester, Manchester, UK, Email:
Department of Oncology, University of Manchester, Manchester, UK

Received: 05-Jul-2024, Manuscript No. jio-24-145800; Editor assigned: 08-Jul-2024, Pre QC No. P-145800; Reviewed: 19-Jul-2024, QC No. Q-145800; Revised: 24-Jul-2024, Manuscript No. R-145800; Published: 31-Jul-2024 , DOI: 10.37421/2329-6771.2024.13.505
Citation: Breyn, Ankur. “Exploring the Intersection of Dental Care and Oncology: Addressing Oral Health in Cancer Therapy.” J Integr Oncol 13 (2024): 505.
Copyright: © 2024 Breyn A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Cancer therapy, encompassing various modalities such as chemotherapy, radiotherapy, and targeted therapies, has profoundly improved patient outcomes. However, these treatments often come with significant side effects that impact patients' overall well-being, including their oral health. The intersection of dental care and oncology is critical for addressing these challenges, as the oral cavity can be a site of both treatment-related complications and disease manifestations. This article explores the essential role of dental care within oncology, highlighting the impact of cancer treatments on oral health, and discusses strategies for managing these effects to improve patient quality of life. The high doses of radiation can impair the blood supply to the jawbone, leading to tissue necrosis. This condition manifests as bone pain, exposed bone, and delayed healing of oral wounds. Management of microsites often involves a combination of topical treatments, pain management, and adjustments to diet to alleviate symptoms and promote healing. For patients undergoing chemotherapy or radiotherapy, maintaining optimal oral hygiene is essential to prevent secondary infections and complications.

Description

Cancer treatments can cause a range of oral health issues due to their systemic effects. Chemotherapy, for instance, targets rapidly dividing cells, which include not only cancer cells but also those in the oral mucosa, leading to conditions such as mucositis. Mucositis is characterized by painful inflammation and ulceration of the oral mucosa, which can interfere with eating, speaking, and maintaining oral hygiene. Chemotherapy can also cause xerostomia (dry mouth) due to damage to the salivary glands, increasing the risk of dental caries and oral infections [1]. Particularly when applied to head and neck cancers, can lead to significant oral health complications. The exposure to radiation can damage salivary glands, resulting in chronic xerostomia and a higher likelihood of caries, periodontal disease, and mucosal infections. Additionally, radiation-induced damage to bone tissue can result in osteoradionecrosis, a serious condition that involves bone necrosis and chronic pain. Targeted Therapies and immunotherapies have their own set of oral side effects. These therapies, while more specific, can still cause mucosal changes, altered taste perception, and dry mouth. For example, some targeted therapies may result in oral mucositis or exacerbate pre-existing oral conditions. Integrating dental care into oncology treatment plans is crucial for managing and mitigating these side effects [2]. Preventive dental care plays a proactive role in minimizing the impact of cancer treatments. This includes pre-treatment dental evaluations to address any existing oral issues and establish a baseline for on-going care. Dentists can provide interventions such as fluoride treatments, dental sealants, and customized oral hygiene recommendations to protect teeth and mucosa during treatment.

Management of mucositis often involves a combination of topical treatments, pain management, and adjustments to diet to alleviate symptoms and promote healing. For patients undergoing chemotherapy or radiotherapy, maintaining optimal oral hygiene is essential to prevent secondary infections and complications. Addressing xerostomia includes recommending the use of artificial saliva products and oral moisturizers, as well as advising on dietary changes that can help alleviate dry mouth. Salivary gland stimulation techniques, such as sialogogues or mechanical stimulation, can also be beneficial. Osteoradionecrosis requires careful monitoring and preventive strategies. Ensuring that any potential sources of infection are addressed before initiating radiotherapy can reduce the risk of this condition. For patients who develop osteoradionecrosis, management might involve conservative measures such as hyperbaric oxygen therapy, along with surgical intervention if necessary [3].

Effective management of oral health in cancer therapy also hinges on patient education and interdisciplinary collaboration. Educating patients about the potential oral side effects of their treatment and providing guidance on how to manage them can empower them to take an active role in their care. This includes teaching proper oral hygiene practices, recognizing early signs of complications, and understanding the importance of regular dental checkups. Collaboration between oncologists and dental professionals is essential to ensure comprehensive care. A coordinated approach allows for timely interventions and adjustments to the treatment plan based on the patient’s oral health status. Regular communication between the oncology team and dental providers can help in managing side effects and addressing any issues that arise during treatment. Advancements in cancer therapy and dental care continue to evolve, with promising developments on the horizon. New technologies and research are focused on minimizing the oral side effects of cancer treatments. Innovations such as targeted radiotherapy techniques, which aim to reduce collateral damage to healthy tissues and the development of novel therapeutic agents to manage side effects, are actively being explored.

Additionally, research into the role of oral micro biomes in cancer therapy outcomes is gaining traction. Understanding how the oral micro biome interacts with cancer treatments could lead to new strategies for preventing and managing oral complications. Prior to radiotherapy, dental issues such as infections or decayed teeth should be addressed to reduce the risk of osteoradionecrosis. Post-radiotherapy, maintaining oral hygiene and monitoring for signs of bone necrosis are essential. In cases where osteoradionecrosis does occur, management often includes conservative measures such as hyperbaric oxygen therapy and, if necessary, surgical debridement. Patient Education is crucial for improving outcomes. Educating patients about the potential dental complications of radiotherapy and the importance of rigorous oral hygiene can empower them to take an active role in their care. Patients should be informed about the benefits of fluoride treatments, the use of salivary substitutes, and the need for regular dental visits [4]. Emerging research into radiotherapy's effects on dental health is on-going, with new strategies and technologies being explored to better manage and mitigate these complications. Advances in radiation technology, such as Intensity-Modulated Radio Therapy (IMRT) and proton therapy, offer the potential for more precise targeting of tumours with reduced damage to surrounding healthy tissues, which may lessen the severity of dental side effects. Additionally, novel therapeutic approaches, including regenerative medicine and tissue engineering, hold promise for repairing radiation-induced damage and improving outcomes for affected patients. Collaborative research efforts between oncologists, dental professionals, and researchers are vital in advancing these innovations and improving the overall management of dental health in cancer patients [5].

Conclusion

The intersection of dental care and oncology underscores the importance of a multidisciplinary approach in managing the oral health of cancer patients. The impact of cancer therapies on the oral cavity can significantly affect patients' quality of life, but with proactive management and collaborative care, many of these effects can be mitigated. By integrating dental care into the oncology treatment plan, healthcare professionals can enhance patient outcomes, improve comfort, and support overall well-being throughout the cancer treatment journey. Continued research and innovation in both fields hold promise for even better strategies to address the complex challenges faced by cancer patients regarding oral health. Continued research and collaboration across disciplines will be essential to overcoming current challenges and realizing the full potential of these therapies in clinical applications.

Acknowledgement

None.

Conflict of Interest

None.

References

  1. Speight, Paul M., Joel Epstein, Omar Kujan and Mark W. Lingen, et al. "Screening for oral cancer—a perspective from the Global Oral Cancer Forum.Oral Surg Oral Med Oral Pathol Oral Radiol 123 (2017): 680-687.

    Google Scholar, Crossref, Indexed at

  2. Rutkowska, Monika, Sylwia Hnitecka, Marek Nahajowski and Marzena Dominiak, et al. "Oral cancer: The first symptoms and reasons for delaying correct diagnosis and appropriate treatment.Adv Clin Exp Med 29 (2020): 735-743.

    Google Scholar, Crossref, Indexed at

  3. Tripathy, Nirmalya, Rafiq Ahmad, Seung Hyuck Bang and Gilson Khang, et al. "Outstanding antibiofilm features of quanta-CuO film on glass surface." ACS Appl Mater Interfaces 8 (2016): 15128-15137.

    Google Scholar, Crossref, Indexed at

  4. Xiang, Fan, Robyn Lucas, Simon Hales and Rachel Neale, et al. "Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: Empirical relationships." JAMA Dermatol 150 (2014): 1063-1071.

    Google Scholar, Crossref, Indexed at

  5. Kaufman, Howard L., Kim Margolin and Ryan Sullivan. "Management of metastatic melanoma in 2018." JAMA Oncol 4 (2018): 857-858.

    Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 495

Journal of Integrative Oncology received 495 citations as per Google Scholar report

Journal of Integrative Oncology peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward